This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Robert Michael Kennedy
Introduction
Robert Michael Kennedy is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cholesterol levels. His work has implications for treating conditions related to high cholesterol and lipid levels.
Latest Patents
Kennedy holds a patent for "Pyrrole-based HMG-CoA reductase inhibitors." This patent includes HMGCo-A reductase inhibitor compounds that are useful as hypocholesterolemic and hypolipidemic agents. The patent also covers pharmaceutical compositions of these compounds, along with methods of making and using them.
Career Highlights
Kennedy is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on innovative solutions for managing cholesterol and related health issues.
Collaborations
Throughout his career, Kennedy has collaborated with esteemed colleagues such as William Keun-Chan Park and Bruce D Roth. These collaborations have further enhanced the research and development of effective pharmaceutical compounds.
Conclusion
Robert Michael Kennedy's contributions to the field of pharmaceuticals, particularly through his patent on HMG-CoA reductase inhibitors, highlight his role as an influential inventor. His work continues to impact the medical community and offers hope for improved treatments for cholesterol-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile